Butyrate-Loaded Chitosan/Hyaluronan Nanoparticles: A Suitable Tool for Sustained Inhibition of ROS Release by Activated Neutrophils

Autor: Fabio Tentor, Pasquale Sacco, Renzo Menegazzi, Massimiliano Borgogna, Sergio Paoletti, Eleonora Marsich, Kåre Andre Kristiansen, Kjell Morten Vårum, Eva Decleva
Přispěvatelé: Sacco, Pasquale, Decleva, Eva, Tentor, Fabio, Menegazzi, Renzo, Borgogna, Massimiliano, Paoletti, Sergio, Kristiansen, Kåre Andre, Vårum, Kjell Morten, Marsich, Eleonora
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
human neutrophils
Polymers and Plastics
Neutrophils
Sus scrofa
02 engineering and technology
Neutrophil Activation
chemistry.chemical_compound
Superoxides
Hyaluronic acid
Materials Chemistry
Hyaluronic Acid
Internalization
butyrate
chitosan/hyaluronan nanoparticles
inflammation
reactive oxygen species
media_common
chemistry.chemical_classification
chitosan/hyaluronan nanoparticle
Superoxide
021001 nanoscience & nanotechnology
Controlled release
Endocytosis
Cell biology
Butyrates
Biochemistry
Tumor necrosis factor alpha
medicine.symptom
0210 nano-technology
Biotechnology
media_common.quotation_subject
Bioengineering
Inflammation
human neutrophil
Butyrate
Biomaterials
03 medical and health sciences
Cell Adhesion
medicine
Animals
Humans
Chitosan
Reactive oxygen species
Tumor Necrosis Factor-alpha
Mucins
Hydrogen Peroxide
Fibronectins
Drug Liberation
030104 developmental biology
chemistry
Nanoparticles
Zdroj: Sacco, P, Decleva, E, Tentor, F, Menegazzi, R, Borgogna, M, Paoletti, S, Kristiansen, K A, Vårum, K M & Marsich, E 2017, ' Butyrate-Loaded Chitosan/Hyaluronan Nanoparticles: A Suitable Tool for Sustained Inhibition of ROS Release by Activated Neutrophils ', Macromolecular Bioscience, vol. 17, no. 11, 1700214 . https://doi.org/10.1002/mabi.201700214
Popis: Tissue damage caused by excessive amounts of neutrophil-derived reactive oxygen species (ROS) occurs in many inflammatory diseases. Butyrate is a short-chain fatty acid (SCFA) with known anti-inflammatory properties, able to modulate several neutrophil functions. Evidence is provided here that butyrate inhibits neutrophil ROS release in a dose and time-dependent fashion. Given the short half-life of butyrate, chitosan/hyaluronan nanoparticles are next designed and developed as controlled release carriers able to provide cells with a long-lasting supply of this SCFA. Notably, while the inhibition of neutrophil ROS production by free butyrate declines over time, that of butyrate-loaded chitosan/hyaluronan nanoparticles (B-NPs) is sustained. Additional valuable features of these nanoparticles are inherent ROS scavenger activity, resistance to cell internalization, and mucoadhesiveness. B-NPs appear as promising tools to limit ROS-dependent tissue injury during inflammation. Particularly, by virtue of their mucoadhesiveness, B-NPs administered by enema can be effective in the treatment of inflammatory bowel diseases.
Databáze: OpenAIRE